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Abstract
Background: Lutein is an important eye-protective nutrient. This study investigates the protective effects and
mechanisms of lutein on lipopolysaccharides (LPS)-induced uveitis in mice.
Methods: Lutein, suspended in drinking water at a final concentration of 12.5 and 25 mg/mL, was administered to
mice at 0.1 mL/10 g body weight for five consecutive days. Control and model group received drinking water only.
Uveitis was induced by injecting LPS (100 mg per mouse) into the footpad in the model and lutein groups on day
5 after the last drug administration. Eyes of the mice were collected 24 hours after the LPS injection for the
detection of indicators using commercial kits and reverse transcription-polymerase chain reaction.
Results: LPS-induced uveitis was confirmed by significant pathological damage and increased the nitric oxide level
in eye tissue of BALB/C mice 24 hours after the footpad injection. The elevated nitric oxide level was significantly
reduced by oral administration of lutein (125 and 500 mg/kg/d for five days) before LPS injection. Moreover, lutein
decreased the malondialdehyde content, increased the oxygen radical absorbance capacity level, glutathione, the
vitamin C contents and total superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities. Lutein further
increased expressions of copper-zinc SOD, manganese SOD and GPx mRNA.
Conclusion: The antioxidant properties of lutein contribute to the protection against LPS-induced uveitis, partially
through the intervention of inflammation process.
Background
Uveitis, a common ophthalmic disorder responsible for
approximately 10% of blindness in western countries
[1,2], may be caused by autoimmune disorders, infec-
tions or exposure to toxins. In experimental research,
injection of endotoxins such as lipopolysacharide (LPS)
is used to induce uveitis in susceptible animal species
such as rats and mice [3,4]. LPS-induced uveitis in
rodents mimics human uveitis, and is used as an animal
model of pathogenesis of uveitis to evaluate the thera-
peutic efficacy of drugs [5]. Increased inflammatory
markers such as cyclooxygenase-2 (COX-2) and induci-
ble-nitric oxide synthase (iNOS) result in the breakdown
of blood-ocular barrier and infiltration of leukocytes into
ocular tissues, leading to LPS-induced uveitis [6].
Inflammation is considered as the cause for the LPS-
induced uveitis. Previous research indicated that LPS
initiated a cascade of signaling reactions not only to the
expression of inflammatory cytokines, chemokines and
other inflammatory markers, but also activated redox-
sensitive transcription factors and increased the reactive
oxygen species (ROS) level [7]. However, little attention
has been paid to the role of oxidative stress in the devel-
opment of LPS-induced uveitis.
Recently, we confirmed that ROS plays an important
role in mediating the inflammatory signals induced by
LPS and that natural antioxidants exert protective
effects on the LPS-induced uveitis [8]. Meanwhile, we
screened various natural products using the LPS-
induced mouse uveitis model and found that lutein pos-
sesses the most potent bioactivities.
Lutein, concentrated in a small area of the retina
called macula, protects the eye against oxidative stress
and is one of the most commonly found carotenoids in
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any medium, provided the original work is properly cited.fruits and vegetables [9]. In recent years, research has
been focused on the importance of lutein in eye health,
such as protecting vision and cataracts [10]. Studies
found that an increase in macula pigmentation lowers
the risk for eye diseases and that lutein intake is corre-
lated with pigmentation in eyes [11,12]. Randomized
clinical trials found that visual functions are improved
by lutein alone or lutein-included nutrients [13]. Inhibi-
tory effects of lutein on the LPS-induced uveitis in rats
were also reported and mechanistic studies on the
mouse macrophage cell line (RAW264.7 cells) were car-
ried out [9].
The antioxidant properties of lutein may have protec-
tive effects against LPS-induced uveitis. To confirm this,
the present study aims to investigate the effects of lutein
on the changes of lipid peroxidation products, antioxi-
dant capacity and gene expressions of antioxidase in the
whole eye of mice.
Methods
Chemicals
Lutein was supplied by JF-Natural Ltd. (China) (batch
No: 0903110-24). Commercial kits of Coomassie brilli-
ant blue, malondialdehyde (MDA), total superoxide dis-
mutase (SOD) and glutathione peroxidase (GPx) were
purchased from Jiancheng Bioengineering Institute
(China). LPS from Salmonella typhimurium was pur-
chased from Sigma-Aldrich (USA). Glutathione (GSH)
was purchased from Kohjin Co Ltd (Japan).
Animals and treatments
Seven-week-old male BALB/C mice were purchased
from Guangdong Medical Laboratory Animal Center
(China). Mice were kept in a specific room with room
temperature at 23 ± 1°C and a 12-hour light-dark cycle
(lights on from 06:00 to 18:00). Prior to the experi-
ments, the animals were acclimatized for one week with
standard laboratory diet and water. Mice were then arbi-
trarily divided into four groups of 18 animals each.
Experimental groups received oral administration of
lutein suspended in drinking water at a concentration of
12.5 and 25 mg/mL, while control and model group
received drinking water only. Intake of the lutein sus-
pension was 0.1 mL/10 g body weight for five consecu-
tive days. On the fifth day, uveitis was induced in the
experimental groups by injecting LPS diluted in saline at
100 mg per mouse into the mouse footpad. All mice
were sacrificed 24 hours after the injection of LPS in an
ether atmosphere and the eyes were collected immedi-
ately. The care and treatment of the animals were con-
ducted in accordance with the Guide for the Care and
Use of Laboratory Animals by the United States
National Institutes of Health (NIH publication no. 85-
23, revised 1985).
Measurement of the nitric oxide level
Nitric oxide (NO) level of 40% eye homogenate was
determined by the Griess method [14]. Briefly, a 40 μL
sample was transferred into 96-well microplates, and
160 μL Griess reagent, consisting of 1% sulfanilamide,
0.1% N-(1-naphthyl) ethylenediamine hydrochloride and
2.5% H3PO4, was added at room temperature. After 20
minutes, the purple azo-dye was detected at 540 nm
with a MK3 microplate reader (Labsystems, Finland).
Measurement of the MDA and ORAC levels
We used an MDA commercial kit (Jiancheng Bioengi-
neering Institute, China) to measure the MDA level of
the 40% eye homogenate. We measured the ORAC level
of the 4% eye homogenate using a previously described
method [15].
Measurement of the GSH and vitamin C levels
The 40% eye homogenate was deproteinized by adding
3% PCA (1:1) and then centrifuged at 12,000 rpm
(13201×g, Sigma, USA) for 15 minutes at 4°C. The
supernatant was filtered through a 0.45 μmf i l t e rd i s k .
Glutathione and vitamin C levels in the filtrate were
determined by high-performance liquid chromatography
(HPLC, Hitachi, Japan) as previously described [8].
Measurement of SOD and GPx activities
Protein concentration of eye homogenate (1%) was
determined with a Coomassie brilliant blue kit (Jian-
cheng Bioengineering Institute, China). The total super-
oxide dismutase and glutathione activities were detected
using 40% eye homogenate by SOD and GPx kits (Jian-
cheng Bioengineering Institute, China).
Measurement of mRNA expression of SOD and GPx
Gene expression levels of antioxidase were semi-quanti-
tatively assessed with reverse transcription-polymerase
chain reaction (RT-PCR). Total RNA was extracted with
the Trizol reagent from the samples according to the
manufacturer’s protocol (Invitrogen, USA). A total of 3
μg of RNA was reverse-transcribed into cDNA at 42°C
for one hour in 20 μL reaction mixture containing
mouse moloney leukemia virus reverse transcriptase
(Tiangen, China) with oligo (dT)15 primer (Tiangen,
China), followed by polymerase chain reaction (PCR).
PCR (Veriti, USA) was performed with 1 μL cDNA, 2.5
μL 10 × Taq reaction buffer (Tiangen, China), 2 μL
dNTP mixture, 1 μMf o r w a r dp r i m e r ,1μM reverse pri-
mer, 1 μL Taq polymerase (Tiangen, China) in a total
volume of 25 μL. The cDNA was amplified with specific
primers for 30 cycles, beginning at 94°C for 30 seconds,
then at an annealing temperature of 58°C for 40 sec-
onds, and 72°C for 50 seconds, with final incubation at
72°C for seven minutes. The sequences of PCR primers
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phoresed on a 1% agarose gel and visualized with ethi-
dium bromide staining. The band intensity of ethidium
bromide fluorescence was measured with an image ana-
lysis system (Bio-Rad, USA), and then quantified with
Quantity One analysis software (Bio-Rad, USA) and
expressed as the ratio to b-actin.
Statistical analysis
The data were presented as mean ± standard deviation
(SD). Statistical analysis of data was performed with an
SPSS 13.0 statistical package (IBM, USA). One-way ana-
lysis of variance (ANOVA) was used to analyze data dif-
ferences among groups, followed by Dunnett’s
significant post-hoc test for correcting multiple pair-wise
comparisons. Differences were considered as statistically
significant when P < 0.05.
Results
Effects of lutein on the NO levels
The LPS-induced uveitis was confirmed by significant
retinal edema and hemorrhage (Figure 1). The anti-
inflammatory effects of lutein on the LPS-induced uvei-
tis were investigated by determining the NO levels in
the eyes of the mice treated with LPS. As shown in Fig-
ure 2, the NO level in the eye tissue of the control mice
was 19.3 ± 2.1 μmol/mL. An increase (44.9 ± 3.2 μmol/
mL, P = 0.00138) was observed in the model mice.
However, when mice were pre-treated with lutein (125
and 500 mg/kg/d for five days), the NO levels were sig-
nificantly decreased to 35.2 ± 3.3 and 31.3 ± 2.5 μmol/
mL (P = 0.00816; 0.00593) respectively.
Effects of lutein on the MDA and ORAC levels
MDA and ORAC levels of the eye homogenate are indi-
cative of the oxidative damage and anti-oxidative capa-
city respectively. As shown in Figure 3A, the MDA
levels in the eyes of the model group were significantly
increased from 0.66 ± 0.04 to 1.29 ± 0.05 nmol per
milligram of proteins (P = 0.00261). By contrast, the
basal values of ORAC in the eye homogenate of the
control mice were 744.5 ± 1.4 U/mL, and LPS injection
decreased the ORAC level to 65% of the control group.
However, lutein administrations (125 and 500 mg/kg/d
Table 1 Sequences of the oligonucleotides used as primers
mRNA Sequence (5’ to 3’) Length (base pair) Accession no.
CuZnSOD F: 5’-ATGGCGATGAAAGCGGTGTG-3’
R: 5’-TTACTGCGCAATCCCAATCAC-3’
456 NM_011434
MnSOD F: 5’-AAGCACAGCCTCCCAGACCT-3’
R: 5’-TCACTTCTTGCAAGCTGTGTATCTT-3’
597 NM_013671
GPx F: 5’-GAAGTGCGAAGTGAATGG-3’
R: 5’-TGGGACAGCAGGGTTT-3’
255 NM_008160
b-actin F: 5’-GAGGGAAATCGTGCGTGAC-3’
R: 5’-GCTGGAAGGTGGACAGTGAG-3’
446 NM_007393
GenBank accession numbers of cDNA and corresponding genes are available at http://www.ncbi.nlm.nih.gov/.
F: forward primer; R: reverse primer
Figure 1 Microscopic image of the eye tissues obtained from the LPS-treated mice. Photomicrographs of hematoxylin-eosin-stained
sections of eyes from (A) control group and (B) model group 24 hours after the LPS injection. Views of the posterior chamber (PC) and retina
(R); magnification ×400
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reduced the MDA levels to 0.81 ± 0.04 and 0.71 ± 0.03
nmol/mg protein (P = 0.00468) (Figure 3A), and signifi-
cantly raised the ORAC levels to 576.4 ± 21.6 and 608.0
±1 1 . 6U / m L( P = 0.00597; 0.00384) respectively (Figure
3B).
Effects of lutein on the GSH and vitamin C levels
Small-molecule antioxidants (ie GSH and vitamin C)
were detected in the eyes of the mice. As shown in Fig-
ure 4, the GSH levels in the eyes of the model group
were significantly lowered from 180.3 ± 17.1 to 135.5 ±
15.2 μg/g tissues (P = 0.00732). Lutein administrations
(125 and 500 mg/kg/d for five days) significantly
increased the GSH level to 160.0 ± 15.3 and 172.0 ±
20.2 μg/g tissue (P = 0.02924; 0.00719) in the eyes of
the mice treated with LPS. Similarly, LPS decreased the
vitamin C levels from 430.2 ± 35 to 340.6 ± 29.0 μgp e r
gram of tissue (P = 0.00618). Lutein administrations
(125 and 500 mg/kg/d for five days) significantly low-
ered the vitamin C levels to 380.6 ± 15.0 and 390.7 ±
29.1 μg per gram of tissue (P = 0.00833; 0.00509)
respectively.
Effects of lutein on the total SOD and GPx activities
The activities of free oxygen radical scavenger enzymes
were investigated by determining the SOD and GPx
Figure 2 Effects of lutein on the NO levels in the eyes of the
mice treated with LPS. Seven-week-old male BALB/C mice were
injected with LPS in the footpad at 100 mg per mouse. The results
are presented as mean ± SD obtained from 18 animals in each
group. ##P < 0.01: significantly different from the control group and
**P < 0.01: from the model group
Figure 3 Effects of lutein on the MDA and ORAC levels in the eyes of the mice treated with LPS. Seven-week-old male BALB/C mice were
injected with LPS in the footpad at 100 mg per mouse. The results are presented as mean ± SD obtained from 18 animals in each group. ##P <
0.01: significantly different from the control group and **P < 0.01: from the model group
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SOD activity in the model group was significantly low-
ered to 0.35 ± 0.01 U per milligram of proteins (P =
0.00604). Similarly, LPS decreased the GPx activities to
17.3 ± 0.9 U per milligram of proteins (P = 0.00788).
However, lutein administrations (125 and 500 mg/kg/d
for five days) increased the SOD activities to 0.5 ± 0.02
and 0.6 ± 0.03 U per milligram of protein (P = 0.00573;
0.00422), and raised the GPx activities to 24.02 ± 0.82
and 24.6 ± 1.0 U per milligram of protein (P = 0.00392;
0.00310) respectively (Figure 5).
Effects of lutein on the expression of the CuZnSOD,
MnSOD and GPx mRNA levels
Compared with the control group, all expression levels
of CuZnSOD, MnSOD and GPx mRNA in the model
group decreased (P = 0.00487; 0.00372; 0.00703). Lutein
(125 and 500 mg/kg/d for five days) enhanced the
mRNA expressions of CuZnSOD (P = 0.0237; 0.00858),
MnSOD (P = 0.00879; 0.00635) and GPx (P = 0.0159;
0.00937) (Figure 6).
Discussion
Our results indicate that cellular infiltration and protein
leakage into the anterior chamber of mice eyes reached
maximum at 24 hours after LPS injection at 100 mg/
mouse. Cytokines play essential roles in the develop-
ment of uveitis. LPS-induced uveitis is often
accompanied by elevated expression of cytokines such
as tumor necrosis factor-a (TNF-a), interleukin-6 (IL-
6), monocyte chemoattractant protein-1 (MCP-1) [16].
Other inflammatory mediators such as NO and prosta-
glandin-E2 (PG-E2) are also involved in the pathogenesis
of LPS-induced uveitis [17]. In this study, the LPS injec-
tion to the mice led to a massive release of NO in eye
tissues. This increase of NO production may be due to
the up-regulated iNOS mRNA expression in response to
LPS [9]. NO is not only a pro-inflammatory mediator,
but also a highly damaging ROS precursor [18]. Excess
NO causes eye damage by the formation of cytotoxic
peroxynitrite which modifies proteins by nitrating tyro-
sine residues, forming dityrosine and oxidizing trypto-
phan and cysteine [19]. Moreover, ROS production can
be induced by LPS injection, while oxidative stress may
promote the production of pro-inflammatory mediators
thereby causing tissue damage [20].
We conducted experiments on the role of oxidative
stress in the development of LPS-induced uveitis. We
found a significant increase of MDA level and decrease
of ORAC level in the eyes of the mice with LPS-induced
uveitis. Endogenous antioxidants (eg GSH and vitamin
C) help eye tissues increase their capability of ROS
quenching [21]. Several studies reported that lutein
intake elevates endogenous antioxidant expressions
[22,23]. In the present study, LPS significantly depleted
GSH and vitamin C and lowered the ORAC level by
Figure 4 Effects of lutein on the GSH and vitamin C levels in the eyes of the mice treated with LPS. Seven-week-old male BALB/C mice
were injected with LPS in the footpad at 100 mg per mouse. The results are presented as mean ± SD obtained from 18 animals in each group.
##P < 0.01: significantly different from the control group and *P < 0.05, **P < 0.01: from the model group
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Our study demonstrated that oral administration of
lutein significantly suppressed the MDA production and
increased the diminished ORAC level in the eyes of the
mice. Oral administration of lutein significantly recov-
ered the GSH and vitamin C levels in the eyes of the
LPS-treated mice, indicating that the antioxidant prop-
erties of lutein help protect against LPS-induced uveitis
Figure 5 Effects of lutein on the total SOD and GPx activities in the eyes of the mice treated with LPS. Seven-week-old male BALB/C
mice were injected with LPS in the footpad at 100 mg per mouse. The results are presented as mean ± SD obtained from 18 animals in each
group. ##P < 0.01: significantly different from the control group and **P < 0.01: from the model group
Figure 6 Effects of lutein on the mRNA expression of CuZnSOD, MnSOD and GPx in the eyes of the mice treated with LPS. (A) Agarose
gel electrophoresis of RT-PCR amplication of CuZnSOD, MnSOD, GPx mRNA and b-actin mRNA. (B) Densiometric analysis of PCR products. Results
were generated as relative intensity units by densitometry and expressed as the ratio to b-actin. The results are presented as mean ± SD
obtained from 18 animals in each group. ##P < 0.01: significantly different from the control group and *P < 0.05, **P < 0.01: from the model
group
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GPx activities, due to the down-regulation of the mRNA
expressions of CuZnSOD, MnSOD and GPx. Lutein
increased both the mRNA expressions and activities of
SOD and GPx, suggesting that lutein can improve anti-
oxidase activities at gene level in LPS-induced uveitis.
Lutein possesses higher antioxidant properties than
other carotenoids. The antioxidant activities of lutein
are almost 10- and 15-folds of those of b-carotene and
lycopene [24]. The ED50 value of lutein as a free radical
scavenger is 0.7 μM[ 2 5 ] .R o c ket al.r e p o r t e dt h a tt h e
mean serum lutein concentration of human was about
0.2 μM under normal dietary intake [26]. As the retinal
and macular concentration of lutein are raised by
lutein-containing food [27], dietary supplement of lutein
may elevate its concentration in tissue, thereby achieving
its protective effects.
Apart from the ROS scavenger property of lutein
[28,29], lutein suppresses the activation of the nuclear
factor (NF)-B and the degradation of the inhibitor-B
(IB) [9]. NF-B, one of the most ubiquitous transcrip-
tion factors, has been suggested to play a key role in
these reactions [30]. Both production and release of
inflammatory cytokines and ROS induced by LPS
depend on inducible gene expression mediated by the
activation of NF-B [31]. Under quiescent conditions,
NF-B is sequestered in the cytosol and bound to the
IB. However, once IB is dissociated from the complex
by lutein, NF-B translocates into the nucleus, leading
to decreased gene transcription of inflammatory cyto-
kines, chemokines and other inflammatory markers such
as iNOS, as well as redox-sensitive transcription factors
[7]. While previous studies reported that lutein reduced
the concentrations of NO, TNF-a, IL-6, PGE-2, MCP-1
and MIP-2 in aqueous humor [9], our results suggest
that the eye-protective effects of lutein may be related
to the alleviation of oxidative stress.
Conclusion
The antioxidant properties of lutein contribute to the
protection against LPS-induced uveitis, partially through
the intervention of inflammation process.
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